Badger Licensing LLC (Badger) today announced that it was awarded a contract by Lihuayi Weiyuan Chemical Co., Ltd. (Lihuayi) to provide its proprietary technology for a 300,000 metric tons per annum grassroots cumene plant in Dongying City, Shandong Province, People′s Republic of China. The contract includes technology license, engineering, start-up services and corresponding training for Lihuayi.
'Badger is committed to bringing reliable, proven technology to our customers at a low operating and capital cost,? said Mark Healey, president of Badger. 'We believe this plant will help Lihuayi become a major player in the Chinese phenolics industry.?
Cumene, a precursor to the production of phenol, bisphenol A and polycarbonate, has seen strong worldwide growth recently, particularly in China. More than nine million metric tons of cumene capacity has been licensed by Badger and its predecessor companies since the technology was introduced in 1995.
Badger Licensing LLC, headquartered in Cambridge, MA, USA, is a venture of affiliates of The Shaw Group (NYSE: SHAW) and ExxonMobil Corporation (NYSE: XOM). Badger Licensing is principally engaged in marketing, licensing, and developing technologies for ethylbenzene, styrene monomer, cumene, and bisphenol A. The venture also supplies basic engineering packages for the licensed processes through Shaw. Catalyst is supplied to Badger′s licensees by ExxonMobil Catalyst Technologies LLC.
Editor's Notes:
1. Badger Licensing LLC is a joint venture between Badger Technology Holdings LLC (affiliate of The Shaw Group Inc.) and Alkylation Licensing LLC (affiliate of ExxonMobil Corporation).
Für den Inhalt des Beitrages ist allein der Autor verantwortlich bzw. die aufgeführte Quelle. Bild- oder Filmrechte liegen beim Autor/Quelle bzw. bei der vom ihm benannten Quelle. Bei Übersetzungen können Fehler nicht ausgeschlossen werden. Der vertretene Standpunkt eines Autors spiegelt generell nicht die Meinung des Webseiten-Betreibers wieder. Mittels der Veröffentlichung will dieser lediglich ein pluralistisches Meinungsbild darstellen. Direkte oder indirekte Aussagen in einem Beitrag stellen keinerlei Aufforderung zum Kauf-/Verkauf von Wertpapieren dar. Wir wehren uns gegen jede Form von Hass, Diskriminierung und Verletzung der Menschenwürde. Beachten Sie bitte auch unsere AGB/Disclaimer!